The Italian registry of pulmonary nontuberculous mycobacteria - IRENE: the study protocol

The Italian registry of pulmonary nontuberculous mycobacteria - IRENE: the study protocol

Authors

  • Stefano Aliberti Department of Pathophysiology and Transplantation, University of Milan; Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milano
  • Luigi Ruffo Codecasa Regional TB Reference Centre, Istituto Villa Marelli, ASST Grande Ospedale Metropolitano Niguarda, Milano
  • Andrea Gori Clinic of Infectious Diseases, "San Gerardo" Hospital-ASST Monza, University Milano-Bicocca, Milano
  • Giovanni Sotgiu Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari
  • Maura Spotti Department of Pathophysiology and Transplantation, University of Milan; Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milano
  • Antonio Di Biagio Clinica Malattie Infettive, Policlinico Ospedale S. Martino, Genoa
  • Andrea Calcagno Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino
  • Stefano Nardini Ospedale Civile, Pulmonary and TB Unit, Vittorio Veneto
  • Baroukh Maurice Assael Department of Pathophysiology and Transplantation, University of Milan; Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milano
  • Enrico Tortoli Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan
  • Giorgio Besozzi StopTB Italia, Milan
  • Maurizio Ferrarese Regional TB Reference Centre, Istituto Villa Marelli, ASST Grande Ospedale Metropolitano Niguarda, Milano
  • Alberto Matteelli WHO Collaborating Centre for TB/ HIV co-infection and TB Elimination, Department of Infectious and Tropical Diseases, University of Brescia, Brescia
  • Enrico Girardi Clinical Epidemiology Unit, National Institute for Infectious Disease “L. Spallanzani, Rome
  • Saverio De Lorenzo E. Morelli Hospital ASST, Reference Center for MDR-TB and HIV-TB, Sondalo
  • Manuela Seia Medical Genetics Laboratory, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan
  • Andrea Gramegna Department of Pathophysiology and Transplantation, University of Milan; Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milano
  • Bruno Del Prato Unit of Interventional Pulmonology, High Speciality “A. Cardarelli” Hospital, Naples
  • Leonardo Terranova ediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan
  • Martina Oriano Department of Pathophysiology and Transplantation, University of Milan; Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milano
  • Nicola Sverzellati Scienze Radiologiche, Dipartimento di Medicina e Chirurgia, Università di Parma, Parma
  • Mehdi Mirsaeidi Miami Veterans Administration Medical Center, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Miami School of Medicine, Miami, FL
  • James D. Chalmers Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee
  • Charles S. Haworth Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge
  • Michael R. Loebinger Host Defence Clinic, Royal Brompton Hospital, London
  • Timothy Aksamit Mayo Clinic College of Medicine, Rochester, MN
  • Kevin Winthrop Oregon Health and Science University, Portland, OR
  • Felix C. Ringshausen Dept of Respiratory Medicine, Member of the German Centre for Lung Research, Hannover Medical School, Hannover
  • Giuliana Previdi Aziende Socio Sanitarie Territoriale Melegnano e della Martesana, Vizzolo Predabissi, Milano
  • Francesco Blasi Department of Pathophysiology and Transplantation, University of Milan; Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milano

Keywords:

NTM, NTM-PD, COPD, M. Avium, M. Intracellulare, Atypical mycobacteria, Bronchiectasis, Cystic fibrosis, Lung transplant, HIV

Abstract

Background: A substantial increase in pulmonary and extra-pulmonary diseases due to non-tuberculous mycobacteria (NTM) has been documented worldwide, especially among subjects suffering from chronic respiratory diseases and immunocompromised patients. Many questions remain regarding the epidemiology of pulmonary disease due to NTM (NTM-PD) mainly because reporting of NTM-PD to health authorities is not mandated in several countries, including Italy. This manuscript describes the protocol of the first Italian registry of adult patients with respiratory infections caused by NTM (IRENE). Methods: IRENE is an observational, multicenter, prospective, cohort study enrolling consecutive adult patients with either a NTM respiratory isolate or those with NTM-PD. A total of 41 centers, including mainly pulmonary and infectious disease departments, joined the registry so far. Adult patients with all of the following are included in the registry: 1) at least one positive culture for any NTM species from any respiratory sample; 2) at least one positive culture for NTM isolated in the year prior the enrolment and/or prescribed NTM treatment in the year prior the enrolment; 3) given consent to inclusion in the study. No exclusion criteria are applied to the study. Patients are managed according to standard operating procedures implemented in each IRENE clinical center. An online case report form has been developed to collect patients’ demographics, comorbidities, microbiological, laboratory, functional, radiological, clinical, treatment and outcome data at baseline and on an annual basis. An IRENE biobank has also been developed within the network and linked to the clinical data of the registry. Conclusions: IRENE has been developed to inform the clinical and scientific community on the current management of adult patients with NTM respiratory infections in Italy and acts as a national network to increase the disease’s awareness. Trial registration: Clinicaltrial.gov: NCT03339063.

Downloads

Published

11-12-2019

Issue

Section

Original Research Articles

How to Cite

1.
Aliberti S, Ruffo Codecasa L, Gori A, Sotgiu G, Spotti M, Di Biagio A, et al. The Italian registry of pulmonary nontuberculous mycobacteria - IRENE: the study protocol. Multidiscip Respir Med [Internet]. 2019 Dec. 11 [cited 2024 Jul. 4];13. Available from: https://mrmjournal.org/index.php/mrm/article/view/101